Skip to content

Opening book details…

About this Medicine article

(223) APOLLO-1: randomized, placebo- and active-controlled phase 3 study investigating oliceridine (TRV130), a novel μ receptor G protein Pathway Selective (μ-GPS) modulator, for management of moderate to severe acute pain following bunionectomy by Skobieranda, F.; Singla, N.; Burt, D.; Soergel, D. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Skobieranda, F.; Singla, N.; Burt, D.; Soergel, D.
Publisher
Elsevier Science; Elsevier ; Churchill Livingstone; Elsevier BV (ISSN 1528-8447)
Published
2017
Language
EN
Field
Medicine (Health Sciences)